[Hub]/) : Traits : Forced vital capacity (FVC) :

chr9:96,326,127-100,114,913

Best TWAS P=4.99e-22 · Best GWAS P=1.66e-28 conditioned to 0.00114

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 GTEx Artery Tibial RP11-435O5.5 0.09 0.04 lasso 2 0.02 7.3e-03 9.91 -9.6 5.0e-22 -0.44 0.25 0.06 TRUE
2 GTEx Breast Mammary Tissue CDC14B 0.16 0.02 enet 21 0.02 3.7e-02 6.11 -5.8 6.9e-09 -0.01 0.02 0.95 FALSE
3 GTEx Breast Mammary Tissue ERCC6L2 0.17 0.02 lasso 4 0.03 1.2e-02 4.61 5.6 1.8e-08 -0.03 0.28 0.03 TRUE
4 GTEx Cells EBV-transformed lymphocytes AAED1 0.17 0.02 lasso 3 0.04 2.4e-02 6.08 5.7 1.3e-08 0.00 0.03 0.68 FALSE
5 GTEx Cells Transformed fibroblasts ERCC6L2 0.19 0.02 enet 34 0.16 4.1e-12 4.54 5.7 9.7e-09 0.02 0.98 0.00 FALSE
6 GTEx Esophagus Muscularis ERCC6L2 0.15 0.10 lasso 6 0.08 8.8e-06 4.73 5.5 3.0e-08 -0.01 0.87 0.01 FALSE
7 GTEx Heart Atrial Appendage RP11-435O5.4 0.18 0.00 lasso 5 0.00 6.2e-01 4.28 -6.7 2.6e-11 0.07 0.07 0.06 TRUE
8 GTEx Liver PTCH1 0.25 0.06 enet 11 0.03 4.9e-02 10.94 9.6 6.7e-22 0.91 0.01 0.94 FALSE
9 GTEx Nerve Tibial HSD17B3 0.14 0.00 enet 20 0.00 2.4e-01 5.75 6.1 1.2e-09 0.04 0.03 0.77 FALSE
10 GTEx Nerve Tibial ZNF367 0.10 0.05 lasso 3 0.02 7.9e-03 5.83 5.5 3.1e-08 0.04 0.06 0.90 FALSE
11 GTEx Spleen PTCH1 0.33 0.08 lasso 8 0.18 1.9e-05 -0.42 7.0 3.3e-12 0.64 0.05 0.75 TRUE
12 GTEx Testis HABP4 0.19 0.22 lasso 9 0.21 1.1e-09 5.84 5.9 3.7e-09 0.02 0.04 0.96 FALSE
13 GTEx Testis C9orf3 0.15 0.00 enet 18 0.00 2.4e-01 -1.56 -5.4 8.3e-08 -0.10 0.06 0.11 TRUE
14 GTEx Thyroid CDC14B 0.15 0.10 lasso 5 0.08 5.3e-07 5.67 -5.4 8.4e-08 -0.03 0.09 0.91 FALSE
15 NTR Blood PTCH1 0.04 0.02 blup 433 0.02 4.1e-08 10.00 7.5 5.9e-14 0.64 0.02 0.98 TRUE
16 NTR Blood ZNF169 0.02 0.00 lasso 6 0.00 1.1e-02 -6.91 -5.2 1.9e-07 0.08 0.08 0.12 TRUE
17 YFS Blood HABP4 0.08 0.09 enet 24 0.11 5.9e-34 4.95 -5.2 2.2e-07 -0.04 0.90 0.10 FALSE
18 YFS Blood PTCH1 0.09 0.05 lasso 8 0.05 1.2e-15 9.98 9.4 3.8e-21 0.95 0.02 0.98 FALSE
19 The Cancer Genome Atlas Breast Invasive Carcinoma CDC14B 0.02 0.01 lasso 1 0.01 3.0e-03 5.91 -5.9 3.5e-09 -0.03 0.02 0.74 FALSE
20 The Cancer Genome Atlas Glioblastoma Multiforme CDC14B 0.16 0.17 blup 41 0.19 2.6e-06 6.08 -5.8 6.6e-09 0.00 0.02 0.97 FALSE
21 The Cancer Genome Atlas Glioblastoma Multiforme HABP4 0.08 0.06 blup 44 0.05 1.6e-02 5.69 -5.9 2.9e-09 -0.05 0.02 0.57 FALSE
22 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma HABP4 0.02 0.02 blup 44 0.02 7.1e-03 6.08 6.0 2.6e-09 0.02 0.02 0.79 FALSE
23 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma CDC14B 0.03 0.02 blup 42 0.02 2.1e-03 6.08 -5.9 2.8e-09 -0.03 0.02 0.85 FALSE
24 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma PTCH1 0.04 0.00 blup 56 0.02 1.6e-03 9.98 5.3 1.2e-07 0.72 0.02 0.28 FALSE
25 The Cancer Genome Atlas Brain Lower Grade Glioma CDC14B 0.05 0.06 lasso 5 0.06 6.5e-07 6.08 -5.9 3.7e-09 -0.01 0.01 0.99 FALSE
26 The Cancer Genome Atlas Brain Lower Grade Glioma HABP4 0.05 0.08 lasso 5 0.08 6.9e-09 6.07 -6.1 8.8e-10 -0.04 0.03 0.97 TRUE
27 The Cancer Genome Atlas Prostate Adenocarcinoma PTCH1 0.02 0.01 blup 54 0.02 1.1e-03 9.58 -7.5 4.6e-14 -0.19 0.06 0.04 FALSE
28 The Cancer Genome Atlas Stomach Adenocarcinoma CDC14B 0.08 0.02 blup 41 0.04 1.0e-03 4.41 -5.5 4.6e-08 -0.05 0.02 0.70 FALSE
29 The Cancer Genome Atlas Thyroid Carcinoma CDC14B 0.05 0.07 blup 42 0.08 4.8e-08 6.06 -5.9 4.8e-09 -0.02 0.02 0.98 FALSE